SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  March 2024 of Rs. 14745.50 millions grew by 12.81 % from Rs. 13071.20 millions.Handsome Net Profit growth of 54.64% reported above the corresponding previous quarter figure of Rs. 2018.70 millions to Rs. 1305.40 millions.Operating Profit saw a handsome growth to 2954.20 millions from 1711.40 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 14745.50 13071.20 12.81 58740.60 51490.00 14.08 58740.60 51490.00 14.08
Other Income 72.30 19.60 268.88 313.20 35.40 784.75 313.20 35.40 784.75
PBIDT 2954.20 1711.40 72.62 10298.40 6678.80 54.20 10298.40 6678.80 54.20
Interest 101.30 135.90 -25.46 544.70 490.00 11.16 544.70 490.00 11.16
PBDT 2852.90 1575.50 81.08 9753.70 6188.80 57.60 9753.70 6188.80 57.60
Depreciation 691.20 735.40 -6.01 2711.40 2729.50 -0.66 2711.40 2729.50 -0.66
PBT 2161.70 840.10 157.31 7042.30 3459.30 103.58 7042.30 3459.30 103.58
TAX 143.00 -465.30 -130.73 377.50 -8.00 -4818.75 377.50 -8.00 -4818.75
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2018.70 1305.40 54.64 6664.80 3467.30 92.22 6664.80 3467.30 92.22
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 20.03 13.09 53.02 17.53 12.97 35.16 17.53 12.97 35.16

Alembic Pharma Share Price

763.55 4.55 (0.60%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×